Trevigen, Inc.

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. The company is located in the I-270 "High technology Corridor" in Gaithersburg, Maryland. Trevigen-brand research products are marketed via the Internet, catalog, journal advertising, direct mail, and telemarketing. Distributor appointments have been made in North America, Europe, and the Pacific Rim. Trevigen also has in place supply agreements with major government and university medical research centers. The company is the recipient of several SBIR grants from the National Institutes of Health, concerning technology development for the analysis of DNA damage. Trevigen has been a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. The previous decade saw a phenomenal increase in the number of investigators studying apoptosis, but only recently has the link between DNA damage and apoptosis received significant attention. We are pleased to continue to support the growing numbers of investigators moving into these overlapping fields of research. A logical extension of our focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation.

Contact Details: 8405 Helgerman Court Gaithersburg Maryland 20877 United States of America Tel: (301)216-2800 Fax: (301)560-4973 Email: info@trevigen.com WWW: www.trevigen.com/

Loading...

BioNews Results for Trevigen, Inc.:
Adherex Technologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:07AM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Ralcorp Holdings Inc, Aqua America Inc, MetroPCS C	Guru Focus:  Nov 16 2009 3:51AM Matching: inc
AngioDynamics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 5:28AM Matching: inc
Advaxis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 7:02AM Matching: inc
Alcon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 6:25AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Trevigen, Inc. news.

Trevigen, Inc. Patents:
US Patent No.	Title
6548247	Detection and mapping of point mutations using partial digestion
5763178	Oscillating signal amplifier for nucleic acid detection
5656430	Oscillating signal amplifier for nucleic acid detection

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 656 times since April 2007, the link to the organisation's website has been followed 80 times

Recent Search Terms used to find this page: trevigen company information | trevigen inc | trevigen | trevigen ceo | trevigen ceo | Trevigen CEO | Trevigen CEO | trevigen product catalog | Trevigen building | trevigen | .

Search for more companies in Gaithersburg

Search for more companies in Maryland

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Trevigen, Inc.